Reference // Terminology
Analytical glossary
The terms used on our product pages, defined for what they cover — and for what they do not. An analytical method demonstrates only what it measures.
Analysis
- Certificate of analysis (CoA) COA · lot report
- A report issued by a laboratory after analysing a sample. It states the methods used, the results obtained and the identifier of the sample. A certificate covers the sample submitted — it does not certify an entire production run.
- Chromatographic purity HPLC purity
- The proportion of the main peak among everything the chromatography detects, expressed as a percentage of the total area. It says nothing about what the method does not detect, and nothing about the mass actually present.
- EC50 EC 50 · half maximal effective concentration
- The concentration of a compound that produces half of its maximal response in a given system. It measures potency, but depends entirely on the cell system, the reporter and the experimental conditions: two EC50 values from different protocols are not comparable. Not to be confused with IC50, which describes inhibition.
- Endotoxin LPS · lipopolysaccharide
- A component of the outer membrane of Gram-negative bacteria. Testing for it is a specific assay (LAL) that forms no part of a peptide identity and purity analysis.
- MALDI-TOF MALDI · MALDI matrix
- Matrix-assisted laser desorption/ionisation coupled to a time-of-flight analyser. The sample is co-crystallised with an organic matrix that absorbs the laser energy and transfers the charge without fragmenting the molecule. An alternative to ESI for confirming identity; the choice of matrix determines the quality of the spectrum.
- Sterility sterile
- The absence of viable micro-organisms, established by its own test over at least fourteen days. It is distinct from the absence of endotoxins, and neither is covered by a chromatographic purity report.
- TFA trifluoroacetic acid
- A counter-ion frequently left over from HPLC purification. It contributes to the weighed mass without being peptide, which is what explains the gap between weighed mass and quantitative content.
Handling
- Aliquoting aliquot
- Dividing a reconstituted solution into several single-use portions. It avoids repeated freeze-thaw cycles and repeated punctures of the same vial, both of which degrade a peptide in solution.
- Bacteriostatic water bac water · BAC
- Water containing about 0.9 % benzyl alcohol as a preservative. The preservative inhibits microbial growth, which is what makes repeated withdrawals from the same vial possible; it does not sterilise a vial that is already contaminated.
- Reconstitution bringing back into solution
- Returning a lyophilisate to solution by adding a solvent. The concentration obtained is the mass in the vial divided by the volume added — there is no second step and no correction factor.
Identification
- CAS number CAS Registry Number
- A unique numeric identifier assigned to a chemical substance by the Chemical Abstracts Service. It designates the substance, never a manufacturer or a quality level.
- Disulfide bridge disulfide bond · disulphide bridge
- A covalent bond between the sulfur atoms of two cysteine residues, which closes or rigidifies a peptide chain. Its presence determines the conformation and therefore the activity; accidental reduction changes the mass by +2 Da per bridge, a difference detectable by high-resolution mass spectrometry.
- Lot number batch number
- The identifier of a single production run. It is what ties a vial to a specific analysis report: a report attached to another lot says nothing about the material you received.
- Molecular weight molar mass · MW
- The mass of one mole of the compound, in g/mol. It is the figure mass spectrometry compares against to confirm identity, which is why a discrepancy of a few daltons is meaningful.
- Peptide sequence amino acid sequence
- The order of the amino acids in the chain, written from the N-terminus to the C-terminus. It is the primary identity of a peptide: two compounds with the same formula but a different order are different compounds.
Method
- DPP-4 DPP4 · dipeptidyl peptidase 4
- A ubiquitous enzyme that inactivates GLP-1 by cleaving its first two N-terminal residues, limiting its half-life to about two minutes. GLP-1 agonists carry substitutions designed to resist that cleavage. Inhibitors of the enzyme are written iDPP4.
- ESI-TOF MS time-of-flight mass spectrometry · electrospray
- Electrospray ionisation coupled to a time-of-flight analyser. It confirms the identity of a compound by measuring its molecular mass, typically to within ±0.5 Da of the theoretical weight.
- Fmoc fluorenylmethyloxycarbonyl
- The protecting group most used in solid phase synthesis, removed under mild basic conditions at each cycle. The alternative chemistry, Boc, requires strong acid, which is why Fmoc became the standard for most research peptides.
- Half-life t½ · elimination half-life
- The time after which the concentration of a compound has fallen by half. For peptides it is generally short: endogenous GLP-1 is inactivated in about two minutes by DPP-4. The structural changes made to analogues — protease-resistant substitutions, lipidation that binds albumin — are aimed precisely at extending it. A reported half-life depends on the model and the route studied.
- Protease proteolysis · peptidase
- An enzyme that catalyses the hydrolysis of peptide bonds; proteolysis is the corresponding reaction. It is the main route by which peptides are degraded biologically, and the reason synthetic peptides often carry modifications intended to slow it down.
- Quantitative content peptide content · assay
- The mass of peptide actually present in the vial, as opposed to the mass weighed out. The difference comes from counter-ions, residual water and residual solvent. A material can be highly pure and still contain less than the labelled mass.
- RP-HPLC reversed-phase high performance liquid chromatography
- A separation method in which the mixture is carried by a mobile phase through a non-polar column. It is used to estimate the chromatographic purity of a peptide and to reveal the profile of related impurities.
- SPPS — solid phase peptide synthesis SPPS
- The dominant synthesis method for peptides: the chain is built residue by residue on an insoluble solid support, which allows excess reagents to be washed away at each cycle without purifying the intermediate. Every cycle is an opportunity for failure, and the truncated sequences that result are the main family of impurities visible on a chromatogram.
Status
- Analytical reference material reference standard
- A substance characterised well enough to serve as a point of comparison in an analysis. The status describes a laboratory use; it carries no authorisation for human or veterinary use.
- In-vitro research in vitro
- Work carried out outside a living organism, on cells, tissues or cell-free systems. Results obtained in this setting do not transfer to a whole organism.
- Medicinal product by presentation medicine by presentation
- Under French law, a product becomes a medicinal product through the way it is presented, as soon as it is offered with properties for treating or preventing disease. The classification follows the claim made, not the molecule — which is why no therapeutic claim appears anywhere on this site.
Storage
- Cold chain cold storage
- The unbroken series of controlled temperatures from production to delivery. For a lyophilisate the constraint is far less strict than for a solution, which is precisely why these materials are supplied freeze-dried.
- Lyophilisation freeze-drying · lyophilised
- Dehydration by sublimation under vacuum at low temperature. The peptide is stabilised as an amorphous powder, which stores better than the corresponding solution.
- Oxidation oxidised
- A degradation reaction that particularly affects methionine, cysteine and tryptophan residues. It adds 16 Da per oxygen atom, which makes it visible by mass spectrometry, and it is one reason lyophilisates are stored away from light and air.
Terminology
- Agonist triple agonist · dual agonist
- A molecule that binds a receptor and triggers its response, as opposed to an antagonist, which blocks it. A dual or triple agonist engages two or three distinct receptors with a single molecule — the principle behind the second and third generation incretins.
- Bioavailability bioavailable
- The fraction of an administered dose that reaches the systemic circulation unchanged. It is very low by the oral route for most peptides, which digestive proteases hydrolyse before absorption — the reason the experimental literature favours parenteral routes for these compounds.
- GHRH and GHSR secretagogue · GHRP vs GHRH
- Two distinct routes into the same axis. A GHRH analogue mimics the hypothalamic hormone that triggers GH release; a GHRP-type secretagogue acts on the GHSR receptor, a parallel route. Engaging both together is studied precisely because the two routes are independent — the principle behind combinations such as CJC-1295 + Ipamorelin.
- Neuropeptide neuropeptides
- A peptide acting as a messenger in the nervous system, as a neurotransmitter or a neuromodulator. Semax, Selank and oxytocin fall into this functional category; the label describes a biological role under study, not a property of the reference material.
- Peptide peptide definition
- A chain of amino acids joined by peptide bonds. The boundary with a protein is conventional: the term peptide is generally used below about fifty residues. A synthetic peptide is produced by coupling the residues one after another, usually on a solid support.
- Peptide bond amide bond
- The covalent amide bond between the carboxyl group of one amino acid and the amine group of the next, formed by the loss of a water molecule. It is this bond that absorbs around 214 nm, the wavelength at which peptides are detected in HPLC.
- Peptide hormone polypeptide hormone
- A hormone whose molecule is a peptide or a polypeptide, as opposed to the steroid hormones. Insulin, glucagon, GLP-1, oxytocin and growth hormone are examples. Not being lipid-soluble, these molecules act on membrane receptors, and they are degraded by proteases — hence their generally short half-life.
- Polypeptide polypeptide chain
- A chain of amino acids longer than an oligopeptide, with no strict upper limit. Usage reserves peptide for short chains, polypeptide for intermediate ones, and protein for chains folded into a functional structure.
Glossaire en français — 44 termes, avec une page par terme →